Dr. Eberlin is a Co-Founder and Chief Scientific Officer of Genio Technologies, Inc. and an Assistant Professor in the Departments of Chemistry, Oncology, and Diagnostic Medicine at the University of Texas at Austin, and an adjunct Assistant Professor in the Department of Surgery at Baylor College of Medicine. Dr. Eberlin is passionate about research at the intersection of chemistry and medicine. She has focused her career on developing innovative mass spectrometry technologies to address critical problems in healthcare.
Dr. Eberlin received her B.S. in Chemistry from the State University of Campinas, her Ph.D. in Analytical Chemistry from Purdue University, and pursued her postdoctoral research in the Department of Chemistry at Stanford University. In 2016, Dr. Eberlin started her independent career as an assistant professor at The University of Texas at Austin. Eberlin is the recipient of many honors and awards for her scientific research, including an NIH Pathway to Independence Award, Forbes 30 under 30 listing in the Healthcare category, a Moore Inventor Fellowship, and most notably a MacArthur “Genius” Fellowship in 2018. Her research program centers around the development and application of novel mass spectrometry technologies in health-related research, with a particular focus on disease detection and diagnosis to improve patient care and clinical outcomes. Dr. Eberlin has published more than 65 research articles in top-rated journals such as PNAS, Science Translational Medicine, Nature Communications, Cancer Research, and Clinical Chemistry.
She is passionate about the representation of women and diversity in science and is an outspoken advocate for promoting women in higher levels of academia as well as leadership.